SCHEMBL7074787

SCHEMBL7074787

c1ccc2c(c1)Cc1c-2sc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIMK1 P53667 3/20 0.44
MAP3K9 P80192 2/20 0.44
MAP3K11 Q16584 2/20 0.44
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA4 P22748 1/20 0.43
CA6 P23280 1/20 0.43
DRD2 P14416 1/20 0.42
DRD1 P21728 1/20 0.42
DRD4 P21917 1/20 0.42
DRD5 P21918 1/20 0.42
DRD3 P35462 1/20 0.42
GPR3 P46089 1/20 0.41
BCHE P06276 2/20 0.38
ACHE P22303 2/20 0.38
MAOA P21397 1/20 0.36
PNMT P11086 1/20 0.36
CES1 P23141 1/20 0.34
CHEK1 O14757 1/20 0.34
DAPK3 O43293 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20402086 0.82 DRD2 (0.39) LIMK1MAP3K9MAP3K11CA1CA2
SCHEMBL16546076 0.82 GPR3 (0.39) LIMK1MAP3K9MAP3K11CA1CA2
SCHEMBL12013258 0.80 GPR3 (0.52) LIMK1DRD2DRD1DRD4DRD5
SCHEMBL13959740 0.79 GPR3 (0.37) LIMK1MAP3K9MAP3K11CA1CA2
SCHEMBL13959766 0.79 DRD2 (0.36) LIMK1MAP3K9MAP3K11CA1CA2
SCHEMBL17792031 0.77 KDM4E (0.42) GPR3L3MBTL1
SCHEMBL7081563 0.77 CA1 (0.45) CA1CA2CA4CA6DRD2
Fluorene SCHEMBL17889181 0.76 GPR3 (0.61) LIMK1MAP3K9MAP3K11CA1CA2
SCHEMBL17010907 0.76 LIMK1 (0.49) LIMK1MAP3K9MAP3K11CA1CA2
SCHEMBL13959784 0.76 GPR3 (0.37) LIMK1MAP3K9MAP3K11DRD2DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116120277-A Synthesis method of 10H-benzo [ b ] indeno [2,1-d ] thiophene-10-ketone compound 陕西师范大学 2023-05-16 CN claimed
JP-10109985-A None JP disclosed
CN-116120277-B Synthesis method of 10H-benzo [ b ] indeno [2,1-d ] thiophene-10-ketone compound 陕西师范大学 2024-04-05 CN disclosed
CN-116120277-B Synthesis method of 10H-benzo [ b ] indeno [2,1-d ] thiophene-10-ketone compound 陕西师范大学 2024-04-05 CN disclosed
CN-116120277-B Synthesis method of 10H-benzo [ b ] indeno [2,1-d ] thiophene-10-ketone compound 陕西师范大学 2024-04-05 CN disclosed
CN-116120277-A Synthesis method of 10H-benzo [ b ] indeno [2,1-d ] thiophene-10-ketone compound 陕西师范大学 2023-05-16 CN disclosed
CN-116120277-A Synthesis method of 10H-benzo [ b ] indeno [2,1-d ] thiophene-10-ketone compound 陕西师范大学 2023-05-16 CN disclosed
CN-116120277-A Synthesis method of 10H-benzo [ b ] indeno [2,1-d ] thiophene-10-ketone compound 陕西师范大学 2023-05-16 CN disclosed
US-10370473-B2 Compound, curable composition, cured product, optical member, and lens FUJIFILM CORPORATION (JP) 2019-08-06 US disclosed
US-8252883-B2 Silicon cluster substituted with a conductive organic material; thin film transistor SAMSUNG ELECTRONICS CO., LTD. (KR) 2012-08-28 US disclosed
US-20080076872-A1 Organic semiconductor composition comprising oligomer compounds, composition for patterning organic smiconductor layer comprising the same, organic semiconductor thin film using the same and organic electronic device employing the thin film SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-03-27 US disclosed
US-20070287220-A1 Organic semiconductor materials using stacking-inducing compounds, compositions comprising such materials, organic semiconductor thin films formed using such compositions, and organic electronic devices incorporating such thin films SAMSUNG ELECTRONICS CO., LTD. (KR) 2007-12-13 US disclosed
US-20070287220-A1 Organic semiconductor materials using stacking-inducing compounds, compositions comprising such materials, organic semiconductor thin films formed using such compositions, and organic electronic devices incorporating such thin films SAMSUNG ELECTRONICS CO., LTD. (KR) 2007-12-13 US disclosed
EP-0832890-B1 Benzo (B) indeno (2,1-D) thiophene compounds, intermediates, processes, compositions, and methods LILLY CO ELI (US) 2003-07-02 EP disclosed
EP-0832890-B1 Benzo (B) indeno (2,1-D) thiophene compounds, intermediates, processes, compositions, and methods LILLY CO ELI (US) 2003-07-02 EP disclosed
US-6133458-A FOR INHIBITING BONE LOSS OR BONE RESORPTION, PARTICULARLY OSTEOPOROSIS, CARDIOVASCULAR-RELATED PATHOLOGICAL CONDITIONS INCLUDING HYPERLIPIDEMIA AND RELATED CARDIOVASCULAR PATHOLOGIES, AND ESTROGEN-DEPENDENT CANCER ELI LILLY AND COMPANY (US) 2000-10-17 US disclosed
US-6133458-A FOR INHIBITING BONE LOSS OR BONE RESORPTION, PARTICULARLY OSTEOPOROSIS, CARDIOVASCULAR-RELATED PATHOLOGICAL CONDITIONS INCLUDING HYPERLIPIDEMIA AND RELATED CARDIOVASCULAR PATHOLOGIES, AND ESTROGEN-DEPENDENT CANCER ELI LILLY AND COMPANY (US) 2000-10-17 US disclosed
JP-H10109985-A BENZO(B)INDENO(2,1-D) THIOPHENE COMPOUND, ITS INTERMEDIATE, ITS PRODUCTION, ITS COMPOSITION, AND ITS USING METHOD ELI LILLY & CO 1998-04-28 JP disclosed
EP-0832890-A1 Benzo (B) indeno (2,1-D) thiophene compounds, intermediates, processes, compositions, and methods ELI LILLY AND COMPANY (US) 1998-04-01 EP disclosed
EP-0832890-A1 Benzo (B) indeno (2,1-D) thiophene compounds, intermediates, processes, compositions, and methods ELI LILLY AND COMPANY (US) 1998-04-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10370473-B2 Compound, curable composition, cured product, optical member, and lens CRYZ, CRYAA, UACA LIMK1 2686/4885MAP3K9 4557/4885MAP3K11 4369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.